Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jake Jacobs

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Gastroenterology|November 12, 2002
Re: Arguedas et al.--Hepatitis A prevention analysisR Jake Jacobs, Allen S Meyerhoff, Raymond S Koff
The American Journal of Gastroenterology|February 28, 2002
The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis AR Jake Jacobs, Raymond S Koff, Allen S Meyerhoff
Public Health Reports (Washington, D.C. : 1974)|October 18, 2003
An economic assessment of pre-vaccination screening for hepatitis A and BR Jake Jacobs, Sammy Saab, Allen S Meyerhoff, et al.
Vaccine|December 7, 2007
Prevalence of hepatitis A virus risk factors in a very low endemic country, SwitzerlandMeichun Mohler-Kuo, Robert Steffen, Matthias Bopp, et al.
The Pediatric Infectious Disease Journal|March 5, 2008
Universal hepatitis A vaccination in the United States: a call for actionJay M Lieberman, Bonnie M Word, R Jake Jacobs, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|September 1, 2007
Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warrantedAlejandro Ellis, Ricardo W Rüttimann, R Jake Jacobs, et al.
The Pediatric Infectious Disease Journal|October 11, 2003
Regional variation in the cost effectiveness of childhood hepatitis A immunizationR Jake Jacobs, David P Greenberg, Raymond S Koff, et al.
Vaccine|June 21, 2005
Cost-effectiveness of universal childhood hepatitis A vaccination in ChileM Teresa Valenzuela, R Jake Jacobs, Oscar Arteaga, et al.
Pharmacotherapy|December 26, 2003
Impact of long-acting growth factors on practice dynamics and patient satisfactionRoy A Beveridge, Robert M Rifkin, Ronald J Moleski, et al.
Pediatrics|January 19, 2008
Projected cost-effectiveness of new vaccines for adolescents in the United StatesIsmael R Ortega-Sanchez, Grace M Lee, R Jake Jacobs, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Gastroenterology|November 12, 2002
Re: Arguedas et al.--Hepatitis A prevention analysisR Jake Jacobs, Allen S Meyerhoff, Raymond S Koff
The American Journal of Gastroenterology|February 28, 2002
The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis AR Jake Jacobs, Raymond S Koff, Allen S Meyerhoff
Public Health Reports (Washington, D.C. : 1974)|October 18, 2003
An economic assessment of pre-vaccination screening for hepatitis A and BR Jake Jacobs, Sammy Saab, Allen S Meyerhoff, et al.
Vaccine|December 7, 2007
Prevalence of hepatitis A virus risk factors in a very low endemic country, SwitzerlandMeichun Mohler-Kuo, Robert Steffen, Matthias Bopp, et al.
The Pediatric Infectious Disease Journal|March 5, 2008
Universal hepatitis A vaccination in the United States: a call for actionJay M Lieberman, Bonnie M Word, R Jake Jacobs, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|September 1, 2007
Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warrantedAlejandro Ellis, Ricardo W Rüttimann, R Jake Jacobs, et al.
The Pediatric Infectious Disease Journal|October 11, 2003
Regional variation in the cost effectiveness of childhood hepatitis A immunizationR Jake Jacobs, David P Greenberg, Raymond S Koff, et al.
Vaccine|June 21, 2005
Cost-effectiveness of universal childhood hepatitis A vaccination in ChileM Teresa Valenzuela, R Jake Jacobs, Oscar Arteaga, et al.
Pharmacotherapy|December 26, 2003
Impact of long-acting growth factors on practice dynamics and patient satisfactionRoy A Beveridge, Robert M Rifkin, Ronald J Moleski, et al.
Pediatrics|January 19, 2008
Projected cost-effectiveness of new vaccines for adolescents in the United StatesIsmael R Ortega-Sanchez, Grace M Lee, R Jake Jacobs, et al.
Pageof 2